Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nath Bio-Genes (India)BOM:537291 -0.10%71 ROC (Joel Greenblatt) % is 29.23% as of Jun. 2026, which is 255% above its 10-year median of 8.23. GuruFocus rates BOM:537291 with a GF Score™ of 71/100 and a GF Value™ of ₹263.02 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 258 Agriculture companies, Nath Bio-Genes (India) ranks worse than 51.55% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Nath Bio-Genes (India)'s annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 29.23%.
The historical rank and industry rank for Nath Bio-Genes (India)'s ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:537291'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -8.18 Med: 8.23 Max: 10.93
Current: 10.64
During the past 13 years, Nath Bio-Genes (India)'s highest ROC (Joel Greenblatt) % was 10.93%. The lowest was -8.18%. And the median was 8.23%.
BOM:537291's ROC (Joel Greenblatt) % is ranked worse than 51.55% of 258
companies
in the Agriculture industry
Industry Median: 11.46
vs BOM:537291: 10.64
Nath Bio-Genes (India)'s 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Nath Bio-Genes (India) ROC (Joel Greenblatt) % Related Terms
Nath Bio-Genes (India) ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Nath Bio-Genes (India)'s ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:537291 vs CTVA, CF, MOS: ROC (Joel Greenblatt) % Comparison
For the Agricultural Inputs subindustry, Nath Bio-Genes (India)'s ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nath Bio-Genes (India) ROC (Joel Greenblatt) % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Nath Bio-Genes (India)'s ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Nath Bio-Genes (India)'s ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 29.23% mean?
Nath Bio-Genes (India) (BOM:537291) has a ROC (Joel Greenblatt) % of 29.23% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Nath Bio-Genes (India) and its competitors. This is 255% above median its historical median of 8.23. According to the industry distribution chart, Nath Bio-Genes (India) ranks #133 out of 258 companies in the Agriculture industry, placing it in the top 51.6%.
Is Nath Bio-Genes (India)'s ROC (Joel Greenblatt) % too high?
Nath Bio-Genes (India)'s current ROC (Joel Greenblatt) % of 29.23% is 255% above median its 10-year median of 8.23. The Agriculture industry median ROC (Joel Greenblatt) % is 11.46. Nath Bio-Genes (India)'s value of 29.23% is 155.1% above this industry median. Based on the distribution chart, Nath Bio-Genes (India) ranks #133 out of 258 companies in the Agriculture industry, which is below the industry midpoint. Overall, Nath Bio-Genes (India) has a GF Score™ of 71/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nath Bio-Genes (India)'s ROC (Joel Greenblatt) % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Nath Bio-Genes (India) ranks #133 out of 258 companies for ROC (Joel Greenblatt) %. This places Nath Bio-Genes (India) in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 11.46. Nath Bio-Genes (India)'s value of 29.23% is 155.1% above this benchmark. While the company's 10-year median is 8.23 vs. the industry median of 11.46, Nath Bio-Genes (India) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for an Agriculture company?
The median ROC (Joel Greenblatt) % among Agriculture companies is 11.46, based on 258 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nath Bio-Genes (India)'s current ROC (Joel Greenblatt) % of 29.23% is 155.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Nath Bio-Genes (India) and its competitors. For the Agriculture industry, the median ROC (Joel Greenblatt) % is 11.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nath Bio-Genes (India)'s current ROC (Joel Greenblatt) % is 29.23%, which is 255% above median its own 10-year median of 8.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nath Bio-Genes (India) stock overvalued right now?
Based on GuruFocus' analysis, Nath Bio-Genes (India) (BOM:537291) is currently considered Possible Value Trap. The stock's GF Value™ is ₹263.02, compared to a current price of ₹153.85 — trading 41.5% below its estimated fair value. The current ROC (Joel Greenblatt) % is 29.23%, which is 255% above median its 10-year median of 8.23 and 155.1% above the Agriculture industry median of 11.46. Nath Bio-Genes (India)'s overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Nath Bio-Genes (India) (BOM:537291), the current ROC (Joel Greenblatt) % is 29.23% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nath Bio-Genes (India) (BOM:537291) Overvalued in 2026?
Based on GuruFocus' analysis, Nath Bio-Genes (India) stock appears to be undervalued.
The current stock price of ₹153.85 is trading 41.5% below its estimated GF Value™ of ₹263.02.
GuruFocus considers Nath Bio-Genes (India) to be Possible Value Trap.
Key valuation signals for BOM:537291:
ROC (Joel Greenblatt) %: 29.23% (255% above median its 10-year median of 8.23)
GF Value™: ₹263.02 vs. price of ₹153.85 (41.5% below fair value)
Industry Position: 155.1% above the Agriculture median (#133 of 258)
No single metric tells the full story. See the BOM:537291 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nath Bio-Genes (India) Ltd is engaged in the business of production, processing, and marketing of Hybrid and GM seeds. The company has a product range of field crops, vegetable crops, and micronutrient supplements. It has developed products across verticals of cotton, paddy, mustard, maize, okra, tomato, gourds, chili, and crop nutrition supplements. The operating segments of the group are Agriculture activities; and Trading activities, of which a majority of revenue is derived from the Agriculture activities segment. Geographically, the group has a business presence in India and other countries, of which key revenue is generated within India.
71GF Score
Get the complete analysis for BOM:537291
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:537291 has been successfully added to your 
